48 related articles for article (PubMed ID: 38630658)
1. Regulation of Hepatocellular Carcinoma Epithelial-Mesenchymal Transition Mechanism and Targeted Therapeutic Approaches.
Yüregir Y; Kaçaroğlu D; Yaylacı S
Adv Exp Med Biol; 2024; 1450():93-102. PubMed ID: 37452258
[TBL] [Abstract][Full Text] [Related]
2. Jolkinolide B inhibits the progression of hepatocellular carcinoma by regulating Musashi-2 protein.
Wu T; Yang H; Li J; Fang H; Shi X; Li J; Feng L
PLoS One; 2024; 19(4):e0299920. PubMed ID: 38630658
[TBL] [Abstract][Full Text] [Related]
3. Long Noncoding RNA AK021443 Promotes Cell Proliferation and Migration by Regulating Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells.
Yang J; Li J; Liu B; Zhang R; Gu F; Zhao J; Cheng S
DNA Cell Biol; 2018 May; 37(5):481-490. PubMed ID: 29638164
[TBL] [Abstract][Full Text] [Related]
4. Ultrasound-Targeted Microbubble Destruction-Mediated miR-206 Overexpression Promotes Apoptosis and Inhibits Metastasis of Hepatocellular Carcinoma Cells Via Targeting PPIB.
Wu H; Xie D; Yang Y; Yang Q; Shi X; Yang R
Technol Cancer Res Treat; 2020; 19():1533033820959355. PubMed ID: 33111654
[TBL] [Abstract][Full Text] [Related]
5. UNC119 promoted cell growth and migration by Wnt/β-catenin signal and TGF-β/EMT signal pathway in hepatocellular carcinoma.
Liu ZH; Zhang YF; Xu ZD; Z H L; Y F Z; Z D X
J BUON; 2018; 23(6):1717-1724. PubMed ID: 30610799
[TBL] [Abstract][Full Text] [Related]
6. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
Wu WL; Wang WY; Yao WQ; Li GD
Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
[TBL] [Abstract][Full Text] [Related]
7. Exosomal miR-374c-5p derived from mesenchymal stem cells suppresses epithelial-mesenchymal transition of hepatocellular carcinoma via the LIMK1-Wnt/β-catenin axis.
Ding B; Lou W; Fan W; Pan J
Environ Toxicol; 2023 May; 38(5):1038-1052. PubMed ID: 36722453
[TBL] [Abstract][Full Text] [Related]
8. Jolkinolide B: A comprehensive review of its physicochemical properties, analytical methods, synthesis and pharmacological activity.
Zhang YY; Yan Y; Zhang J; Xia CY; Lian WW; Wang WP; He J; Zhang WK; Xu JK
Phytochemistry; 2022 Dec; 204():113448. PubMed ID: 36154827
[TBL] [Abstract][Full Text] [Related]
9. Tumor microenvironment involvement in colorectal cancer progression
Novoa Díaz MB; Martín MJ; Gentili C
World J Gastroenterol; 2022 Jul; 28(26):3027-3046. PubMed ID: 36051330
[TBL] [Abstract][Full Text] [Related]
10. Signaling Pathways and Protein-Protein Interaction of Vimentin in Invasive and Migration Cells: A Review.
Karoii DH; Azizi H; Amirian M
Cell Reprogram; 2022 Aug; 24(4):165-174. PubMed ID: 35749708
[TBL] [Abstract][Full Text] [Related]
11. Jolkinolide B induces cell cycle arrest and apoptosis in MKN45 gastric cancer cells and inhibits xenograft tumor growth in vivo.
Zhang H; Qian J; Jin M; Fan L; Fan S; Pan H; Li Y; Wang N; Jian B
Biosci Rep; 2022 Jun; 42(6):. PubMed ID: 35674158
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis.
Tan DJH; Ng CH; Lin SY; Pan XH; Tay P; Lim WH; Teng M; Syn N; Lim G; Yong JN; Quek J; Xiao J; Dan YY; Siddiqui MS; Sanyal AJ; Muthiah MD; Loomba R; Huang DQ
Lancet Oncol; 2022 Apr; 23(4):521-530. PubMed ID: 35255263
[TBL] [Abstract][Full Text] [Related]
13. Jolkinolide B inhibits proliferation or migration and promotes apoptosis of MCF-7 or BT-474 breast cancer cells by downregulating the PI3K-Akt pathway.
Wang Y; Shen SY; Liu L; Zhang XD; Liu DY; Liu N; Liu BH; Shen L
J Ethnopharmacol; 2022 Jan; 282():114581. PubMed ID: 34464697
[TBL] [Abstract][Full Text] [Related]
14. Evidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002-2020).
Haber PK; Puigvehí M; Castet F; Lourdusamy V; Montal R; Tabrizian P; Buckstein M; Kim E; Villanueva A; Schwartz M; Llovet JM
Gastroenterology; 2021 Sep; 161(3):879-898. PubMed ID: 34126063
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
